Abcellera Biologics Inc
F:8QQ
Abcellera Biologics Inc
F:8QQ
Price:
5.43
EUR
-3.04%
Market Closed
Market Cap:
€1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Abcellera Biologics Inc
F:8QQ
|
CA |
|
S
|
Sembcorp Industries Ltd
XMUN:SBOA
|
SG |
|
K
|
Krones AG
XBER:KRN
|
DE |
|
Central Depository Services (India) Ltd
NSE:CDSL
|
IN |
|
Shofu Inc
TSE:7979
|
JP |
|
L
|
Lime Technologies AB (publ)
F:LTX
|
SE |
|
IPH Ltd
ASX:IPH
|
AU |
|
B
|
Boise Cascade Co
XBER:BC0
|
US |
|
S
|
Sensient Technologies Corp
F:SSF
|
US |
|
EnerSys
NYSE:ENS
|
US |
|
E
|
Elvalhalcor Hellenic Copper and Aluminium Industry SA
ATHEX:ELHA
|
GR |
|
St Dupont SA
PAR:DPT
|
FR |
|
Phoenix Group Holdings PLC
LSE:PHNX
|
UK |
|
Moncler SpA
OTC:MONRY
|
IT |
|
Idorsia Ltd
SIX:IDIA
|
CH |
|
Newlat Food SpA
MIL:NWL
|
IT |
|
M
|
Monolithic Power Systems Inc
F:NQG
|
US |
|
Live Nation Entertainment Inc
NYSE:LYV
|
US |
|
O
|
Organon & Co
XMUN:7XP
|
US |
|
Fair Isaac Corp
NYSE:FICO
|
US |
|
CMS Energy Corp
NYSE:CMS
|
US |
Wall St Price Targets
8QQ Price Targets Summary
Abcellera Biologics Inc
Abcellera Biologics Inc
Wall Street analysts forecast 8QQ stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 8QQ is 9.78 EUR with a low forecast of 6.68 EUR and a high forecast of 12.9 EUR.
Lowest Forecast
Price Target
6.68
EUR
23% Upside
Average Forecast
Price Target
9.78
EUR
80% Upside
Highest Forecast
Price Target
12.9
EUR
138% Upside
Abcellera Biologics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8QQ's stock price target?
Price Target
9.78
EUR
9.78
EUR
According to Wall Street analysts, the average 1-year price target for 8QQ is 9.78 EUR with a low forecast of 6.68 EUR and a high forecast of 12.9 EUR.
What is the Revenue forecast for Abcellera Biologics Inc?
Projected CAGR
33%
33%
Over the last 6 years, the compound annual growth rate for Revenue has been 37%. The projected CAGR for the next 8 years is 33%.
